Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of amiodarone-induced thyrotoxicosis type 2
NL-OMON22747Recruiting
- Start
- Mar 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methimazole, prednisone and perchlorate in amiodarone-induced thyrotoxicosis (AIT) (3 arms). Primary endpoints: Achievement of euthyroidism at 3 months and Achievement of euthyroidism at 6 months. Started Mar 2004; status: recruiting.
02
Drugs
methimazoleprednisoneperchlorate
03
Conditions
amiodarone-induced thyrotoxicosis (AIT)
Beyond the preview
Go deeper on NL-OMON22747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22747.